Alpha Tau Medical (DRTS) Shares Outstanding (Weighted Average) (2020 - 2026)

Alpha Tau Medical has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $260.0 for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $260.0, up 116.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $260.0 (up 116.67% YoY), and the FY2025 annual result was $530.0, up 17.78% from the prior year.
• Shares Outstanding (Weighted Average) came in at $260.0 for Q1 2026 at Alpha Tau Medical, down from $530.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $69.4 million in Q4 2023 to a low of $110.0 in Q1 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $390.0 (2025), against an average of $7.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 9482717.16% in 2022 and slumped 100.0% in 2024, its largest moves.
• Alpha Tau Medical's Shares Outstanding (Weighted Average) stood at $63.5 million in 2022, then gained by 9.2% to $69.4 million in 2023, then plunged by 100.0% to $450.0 in 2024, then grew by 17.78% to $530.0 in 2025, then tumbled by 50.94% to $260.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $260.0 (Q1 2026), $530.0 (Q4 2025), and $390.0 (Q3 2025), per Business Quant data.